Toshiba will showcase its proprietary non-contrast magnetic resonance (MR) angiography imaging techniques and a new application of Time-Spatial Labeling Inversion Pulse (Time-SLIP) at the 2011 Radiological Society of North America (RSNA) trade show. To evaluate cerebrospinal fluid (CSF) flow disorders in children and adults, Time-SLIP can visualize CSF flow without the administration of contrast media, making imaging safer for patients.

Toshiba will showcase the Vantage Titan 3.0T MR system at the 2011 Radiological Society of North America (RSNA) trade show. The machine is equipped with multi-phase transmission technology, creating the most homogeneous abdominal and pelvic images on 3.0T systems.

September 27, 2011 — AccessClosure Inc. announced the shipment of its one millionth Mynx unit. The Mynx Vascular Closure Device received U.S. Food and Drug Administration (FDA) approval in May 2007, following with its full commercial launch in September 2007.

September 27, 2011 – Health 2.0 announced the launch of the Novartis CardioEngagement Challenge, asking multi-disciplinary teams of developers to create an interactive solution enabling patients to better manage their cardiovascular health through a customizable, user-friendly interface.

T-wave alternans (TWA) refers to an alternating pattern in the T-wave of the electrocardiogram (ECG) and is recognized as a marker of electrical instability.  Visible or macroscopic alternans was first reported in the context of proarrhythmic conditions including Prinzmetal’s angina and long QT syndrome, and was often found to immediately precede the onset of ventricular tachycardia or fibrillation.  More recently, techniques have been developed to measure microvolt-level T-wave alternans (MTWA) not visible to the human eye.  The presence of MTWA has been linked with increased risk of sudden cardiac arrest (SCA) in several patient populations.  This study presents the case of a patient who experienced VF during the recovery phase of an MTWA stress test.  While there was no visible abnormality on the ECG which would alert to the impending arrhythmia, significant microvolt-level alternans was detected immediately prior to the cardiac arrest.

September 27, 2011 — Occlutech announced its CEO, Tor Peters, has obtained a favorable ruling from the district court in Düsseldorf in patent litigation initiated personally against him by St. Jude AGA Medical. Occlutech is a European developer of implants for treating structural heart disease.

September 27, 2011 — AF Stat released updates to the AFib Educator, a free smartphone app and desktop widget designed to help healthcare providers better explain atrial fibrillation (AFib) to their patients.

September 27, 2011 — A team of physicians, engineers and materials scientists at Children's Hospital Boston and the Massachusetts Institute of Technology (MIT) have created cardiac patches, with cells all beating in time, that could someday help heart attack patients. The devices were created using nanotechnology and tiny gold wires.

September 27, 2011 — Last week’s inclusion of critical congenital heart disease (CCHD) in the standard list of recommended screenings for new babies by the Department of Health and Human Services (HHS) has received support from the American College of Cardiology (ACC).

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now